Drug targets and Drug Delivery
The expression "biological target" is mostly used as a part of pharmaceutical research to depict the native protein in the body whose movement is modified by a drug resulting in a particular impact, which might be an alluring therapeutic impact or an undesirable antagonistic impact. In this specific circumstance, the biological target is usually referred to as a Drug target. Distinguishing the biological origin of a disease, and the potential focuses for intervention, is the initial phase in the discovery of a drug utilizing the reverse pharmacology approach. Various diverse target discovery approaches have been recognized, for example, drug affinity responsive target stability (DARTS).
- Drug Interactions
- Ligand Based Drug Design
- Scoring functions
- Structure Based Drug Design
- Protein crystallography in drug discovery
- Molecular modeling in drug design
- Cancer drug design and discovery
- Drug design strategies
- Transformative concepts for drug design
Related Conference of Drug targets and Drug Delivery
17th International Conference on Tissue Science and Regenerative Medicine
Drug targets and Drug Delivery Conference Speakers
Recommended Sessions
- Biochemsitry and Biophysics
- Cellular and Molecular Biology
- Computational Approaches in Structural Biology
- Crystallography, NMR & Mass Spectrometry
- Determination of 3D structures
- Drug targets and Drug Delivery
- Gene Regulation and Cell Signaling
- Molecular Biology and Biomarkers
- Sequence Analysis
- Structural and Molecular Biology
- Structural Biology and Bioinformatics
- Structural Biology in Cancer Research
- Structural Enzymology
- Structural Genetics and Genomics